Drug Insights

Strategically Search Dicyclomine on Synapse: A How-to Guide

11 February 2024
2 min read

Dicyclomine Hydrochloride, marketed as BENTYL, is an antispasmodic and anticholinergic medication that was approved for use in the USA in 1950 for the treatment of Irritable Bowel Syndrome but has since been withdrawn from the market. The drug is an antagonist of muscarinic acetylcholine receptors (mAChRs). Its chemical name is [bicyclohexyl]-1-carboxylic acid, 2-(diethylamino) ethyl ester, hydrochloride, with a molecular formula of C19H35NO2•HCl. BENTYL was manufactured by Allergan. As an antispasmodic agent, BENTYL worked by relaxing the muscles in the stomach and intestines, reducing symptoms such as abdominal pain and cramping. As an anticholinergic, BENTYL blocked the effects of acetylcholine, a neurotransmitter that plays a role in intestinal motility. Click on the image below to begin the exploration journey of Dicyclomine through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Pliant Therapeutics Reports Favorable Phase 2a Trial Outcomes for Bexotegrast in Liver Fibrosis Suspected Cases
Latest Hotspot
3 min read
Pliant Therapeutics Reports Favorable Phase 2a Trial Outcomes for Bexotegrast in Liver Fibrosis Suspected Cases
11 February 2024
Pliant Therapeutics Reports Positive Phase 2a INTEGRIS-PSC Trial Results for Bexotegrast in Primary Sclerosing Cholangitis with Suspected Liver Fibrosis.
Read →
User-friendly Guide to Find Oxycodone on Synapse
Drug Insights
2 min read
User-friendly Guide to Find Oxycodone on Synapse
11 February 2024
Oxycodone, a potent opioid analgesic, also referred to as a narcotic, is a medication used in the management of pain.
Read →
Acepodia Gets US Approval for Innovative Anti-EGFR Cell Therapy Trial, ACE2016
Latest Hotspot
3 min read
Acepodia Gets US Approval for Innovative Anti-EGFR Cell Therapy Trial, ACE2016
11 February 2024
Acepodia Reveals US Regulatory Approval for Pioneering Anti-EGFR Allogeneic Cell Treatment Trial, Designated as ACE2016.
Read →
Harnessing Synapse for Diazepam Information: Strategies and Tips
Drug Insights
2 min read
Harnessing Synapse for Diazepam Information: Strategies and Tips
11 February 2024
Diazepam, a significant GABAA receptor agonist approved by Waylis in 1963, effectively treats conditions like muscle spasticity, alcohol withdrawal, anxiety disorders, and epilepsy.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.